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Abstract
The developmental trajectories of emotional disorder symptoms during adolescence remain 
elusive, owing in part to a shortage of intensive longitudinal data. In the present study, we charted 
the temporal course of the tripartite model of anxiety and depression—which posits an 
overarching negative affect dimension and specific anhedonia and anxious arousal dimensions—
over adolescence and emerging adulthood in order to construct a developmental map of the core 
dimensions of emotional disorders. We recruited 604 high school juniors, overselecting those at 
high risk for emotional disorders, and assessed the tripartite symptom domains five times annually. 
Latent curve modeling revealed that negative affect and anxious arousal declined over follow up, 
whereas anhedonia did not. Moreover, the correlation in rate of change varied across pairs of 
symptom domains. Change in negative affect was moderately correlated with change in anxious 
arousal, but change in anhedonia was not significantly related to change in any other domain. 
Symptom trajectories, and the pattern of covariation among trajectories, were equivalent across 
gender and comorbidity status. We discuss implications of these findings for developmental 
models of anxiety and depression as well as transdiagnostic frameworks for emotional disorders.
General Scientific Summary
We charted a map of how anxiety and depression grow through adolescence, a period of peak risk 
for emotional disorders. We found that the core elements of anxiety and depression do not develop 
at the same rate or even in the same direction, on average. There may thus be multiple pathways to 
emotional disorder during adolescence.
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Core Dimensions of Anxiety and Depression Change Independently During 
Adolescence
The trajectories of emotional disorder symptoms are perhaps most unstable in adolescence. 
Anxiety and depressive symptom levels can change dramatically during this period, as some 
conditions (e.g., unipolar depression) tend to emerge for the first time and others (e.g., 
phobias) become entrenched (e.g., Hankin & Abramson, 2001; Lewinsohn, Clarke, Seeley, 
& Rohde, 1994; Kessler et al. 2005). Developmental trends in these symptom domains defy 
simple explanations. Not all emotional disorder symptoms change at the same speed, or even 
in the same direction, during adolescence, despite high rates of diagnostic comorbidity (e.g., 
McLaughlin & King, 2015). Moreover, there is wide variation around average trends, 
reflecting a diversity of possible trajectories.
Mapping the arcs of anxiety and depression over adolescence clearly requires intensive 
longitudinal data. There are surprisingly few prospective studies with a follow up structure 
suited to examine the rate and shape of symptom change. The available research generally 
suggests that depressive symptoms increase steadily through adolescence and reach a 
plateau at the transition to adulthood (Galambos, Barker, & Krahn, 2006; Galambos, 
Leadbeater, & Barker, 2004; Ge, Lorenz, Conger, Elder, & Simons, 1994; Kim, Capaldi, & 
Stoolmiller, 2003). However, several studies report zero growth, or even depression 
symptom improvement, from mid- to late-adolescence (e.g., Galambos, Barker, & Krahn, 
2006; Measelle, Stice, & Hogansen, 2006). Anxiety disorder symptoms appear to decline 
gradually over the second decade of life (McGlaughlin & King, 2015; van Oort, Greaves-
Lord, Verhulst, Ormel, & Huizink, 2009), although contradictory results have been reported 
(Leadbeater, Thompson, & Gruppuso, 2012; Olino, Stepp, Keenan, Loeber, & Hipwell, 
2014), and trajectories likely vary across the different anxiety disorders (Hale, Raaijmakers, 
Muris, van Hoof, & Meeus, 2008; van Oort et al., 2009).
A focus on the core dimensions underlying anxiety and depression may provide a more 
coherent picture of emotional disorder symptom change in adolescence. Negative affect is a 
symptom dimension common to the full spectrum of anxiety and depressive disorders, and 
its growth could be responsible for disorders changing together. Structural modeling of the 
emotional disorder domain shows that disorders also are characterized by more specific (i.e., 
unique) psychopathological dimensions, and these could account for divergent symptom 
trajectories (e.g., Krueger, 1999; Markon, 2010; Prenoveau et al., 2010). Traditional 
assessments of emotional disorders do not adequately distinguish the common versus 
specific components of anxiety and depression (Clark & Watson, 1991). Therefore, prior 
longitudinal studies may have overestimated the similarity of emotional disorder trajectories 
by emphasizing shared symptom dimensions of anxiety and depression (e.g., negative 
affect).
The tripartite model—along with closely related formulations, such as the integrative 
hierarchical model (Mineka, Watson, & Clark, 1998) and the trilevel model (Naragon-
Gainey, Prenoveau, Brown & Zinbarg, in press; Prenoveau et al., 2010)—of anxiety and 
depression aims to separate the common and specific symptom dimensions of emotional 
disorders (Clark & Watson, 1991). This model stipulates that (i) negative affect is common 
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to all emotional disorders and is a major reason for their comorbidity, (ii) anhedonia (i.e., 
low positive affect) is more narrowly associated with depression and social anxiety, and (iii) 
anxious arousal is specifically associated with anxiety (especially panic disorder).
A wealth of cross-sectional research has validated the tripartite configuration in diverse 
community and clinical samples (e.g., Kotov, Gamez, Schmidt, & Watson, 2010; Watson, 
Gamez, & Simms, 2005). The dimensions are distinct yet moderately correlated (Naragon-
Gainey, Watson, & Markon, 2009; Watson & Naragon-Gainey, 2014; Watson et al., 1995; 
Zinbarg & Barlow, 1996), explain complex emotional disorder comorbidity patterns (Brown, 
Chorpita, & Barlow, 1998), and have mostly independent etiologies and correlates (e.g., 
Watson et al., 1995).
There has been no systematic research, however, on the temporal course of tripartite model 
dimensions. Therefore, it remains to be seen whether these components of anxiety and 
depression change at the same rate, or in the same direction, over adolescence and young 
adulthood. It is possible that the three dimensions represent distinct routes to emotional 
disorder that follow divergent naturalistic courses. On the other hand, they may converge 
over time to form one common pathway to disorder.
Although the tripartite model was not originally formulated as a developmental theory, some 
hypotheses regarding temporal dynamics can be derived. Negative affect is posited as a 
common thread across emotional disorder symptoms that correlates more highly with the 
other two tripartite model dimensions than they do with each other, and change in negative 
affect might therefore be expected to correlate with change in anhedonia and anxious arousal 
over time. In contrast, anhedonia and anxious arousal are thought to reflect largely 
independent systems, based on unique neurobiological and psychological underpinnings 
(e.g., Forbes & Dahl, 2005; Forbes et al., 2009; Klein, Kotov, & Bufferd, 2011; Kotov, 
Watson, Robles, & Schmidt, 2007). In cross-sectional analyses, these symptom domains 
exhibit appropriate levels of discriminant validity (Brown et al., 1998; Watson et al., 1995). 
Therefore, it could be argued that the developmental trajectories of these dimensions should 
be largely unrelated.
Prior longitudinal research offers little empirical guidance for predictions about correlations 
among developmental trajectories of the core dimensions of anxiety and depression. In one 
early adolescent sample, latent curve modeling analyses revealed no significant correlation 
between change in depressive symptoms and change in generalized, physical, separation, or 
social anxiety symptoms (McLaughlin & King, 2015). In contrast, in a large sample of 
Dutch adolescents, the corresponding estimates (r range: .32-.71) were moderate-to-large 
over five years of follow up (Hale, Raaijmakers, Muris, van Hoof, & Meeus, 2009). Two 
other longitudinal studies also reported substantial correlations (rs ≈ .60) in growth of 
anxiety and depression (Leadbeater et al., 2012; Olino et al., 2014). However, it is important 
to bear in mind that these estimates may be inflated to some extent by negative affect 
pervading the assessment of anxiety and depressive constructs.
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Present Study
In the present study, we charted the growth of basic psychopathological dimensions 
undergirding anxiety and depressive disorders during adolescence and emerging adulthood. 
We examined negative affect, anhedonia, and anxious arousal over five annual assessment 
waves in a high risk sample of high school juniors. We had three research questions. First, 
what are the direction and rate of symptom change? Second, how much variation exists 
around the average symptom trajectory, and do the trajectories from different symptom 
domains covary? Third, do symptom trajectories, and the degree of covariation among those 
trajectories, differ by gender and comorbidity status?
Two opposing theoretical perspectives led to competing hypotheses regarding the trajectory 
of mean-level symptom change (Question 1). On one hand, drawing from data on change in 
personality trait levels over the life course, the maturity principle (Caspi, Roberts, & Shiner, 
2005) holds that people tend to become more emotionally stable at the transition to 
adulthood. That is, negative affect is theorized to wane as people make normative 
commitments to conventional social roles, such as long-term romantic relationships, lifelong 
friendships, occupations, and families (e.g., Robins, Caspi, & Moffitt, 2002; Robins, Fraley, 
Roberts, & Trzesniewski, 2001). Perhaps because entry into many of these stabilizing social 
institutions occurs in emerging adulthood, the transition to young adulthood is the period of 
greatest change (i.e., reduction) in trait negative affectivity (see Roberts, Walton, & 
Viechtbauer, 2006, for a meta-analysis). Therefore, it could be hypothesized that those 
emotional disorder symptom dimensions most saturated with trait negative affectivity—in 
the present study, negative affect and anxious arousal (see Mineka et al., 1998)—should 
show reductions over the present study’s timeframe, which spans the transition from 
adolescence to young adulthood.
On the other hand, the major social transitions accompanying emerging adulthood may 
trigger anxiety and depressive symptoms among vulnerable people. The list of 
developmental challenges at the transition to adulthood is long: for instance, leaving home, 
beginning and ending romantic relationships, succeeding in academics, and choosing a 
career (e.g., Helson, Kwan, John, & Jones, 2002). For that reason, Arnett (2000) referred to 
emerging adulthood as “demographically dense.” Real, perceived, or anticipated failure to 
successfully negotiate any of these age-graded social roles theoretically could provoke 
anxiety and depression, especially among those prone to negative affect. As explained 
below, our participants were over-sampled for adolescents endorsing high levels of trait 
negative affectivity. Thus, consistent with a diathesis-stress viewpoint (e.g., Beck, 1979), it 
could be argued that the transition to adulthood—with the demands of achieving normative 
life tasks more salient than ever—should activate negative affect, anxious arousal, and 
anhedonic symptoms in the present sample (cf. Rohde, Lewinsohn, Klein, Seeley, & Gau, 
2013).
We expected to find significant variability in both the initial level and the amount of change 
across all dimensions (Question 2). Further, based on prior theorizing—albeit mostly in the 
context of cross-sectional symptom associations—about the structure of anxiety and 
depression (e.g., Clark & Watson, 1991), we hypothesized that growth in negative affect 
would, to some extent, correlate with both anhedonia and anxious arousal. In contrast, in line 
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with prior theory and empirical evidence emphasizing their discriminant validity (e.g., 
Mineka et al., 1998), growth in anhedonia and anxious arousal was predicted to be mostly 
independent. As described earlier, these specific dimensions of the tripartite model are 
hypothesized to represent symptom dimensions that are distinctive to different emotional 
disorders.
We examined a pair of background variables theoretically linked to the nature of emotional 
disorder (co)development during adolescence and the transition to adulthood (Question 3). 
We examined gender differences in symptom trajectories in light of the diverging emotional 
disorder prevalence rates during this developmental stage (e.g., Ge, Conger, & Elder 2001). 
We generated competing predictions with respect to gender. On the one hand, women are 
expected to show steeper symptom increases (or flatter declines) because of the higher risk 
for anxiety and depression during this period. On the other hand, if gender differences in 
adolescence are largely mediated by neuroticism (e.g., Eaton et al., 2011), one would expect 
no differences in symptom trajectories across gender because both men and women in the 
present study were over-sampled on the basis of elevated neuroticism (see Methods). We 
also predicted that diagnostic history would influence symptom development. We 
concentrated specifically on those who had a history of anxiety and depressive diagnoses. 
We hypothesized that comorbidity would predict not only the shape of symptom trajectories 
(i.e., steady or increasing symptom patterns), but also the extent to which symptoms 
changed together over time. That is, we expected that comorbid cases, by virtue of 
possessing vulnerabilities for both anxiety and depression, would evidence a stronger 
coupling of change across symptom domains over follow up.
Method
Participants
Participants were part of the Youth Emotion Project (YEP), a longitudinal study of the 
development of emotional disorders. High school juniors were recruited in three cohorts 
from schools in suburban Los Angeles and suburban Chicago. Those students who provided 
assent and parental consent (N = 1,976) were administered the Neuroticism scale of the 
revised Eysenck Personality Questionnaire (EPQ-R-N; Eysenck & Eysenck, 1975). A 
subsample of 1,269 students was invited to participate in the YEP on the basis of EPQ-R-N 
responses, overselecting for those in the highest Neuroticism tertile. There were 627 students 
who completed the baseline assessment. Females were the larger portion of this sample 
(68.7%), owing to greater likelihood of completing the screening questionnaire (56% 
female), scoring higher on the EPQ-R-N, and accepting the invitation to participate. At 
baseline, participants were an average of 16.9 years old (SD = 0.37). Participants identified 
as Caucasian (50.2%), Hispanic/Latino (13.8%), African American (13.4%), Asian/Pacific 
Islander (4.7%), other race/ethnicity (5.3%), and multiracial (12.6%). Additional details 
regarding screening and selection procedures are available elsewhere (Zinbarg et al., 2010).
Measures
Mood and Anxiety Symptom Questionnaire (MASQ; Watson et al., 1995)—The 
90-item MASQ was constructed to assess the general and specific symptom domains of the 
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tripartite model of anxiety and depression. The MASQ has three general dimensions that 
feature symptoms common to multiple anxiety and depressive disorders. The 15-item 
General Distress: Mixed Symptoms scale includes symptoms that appear in the criterion sets 
for both anxiety and depressive conditions (e.g., irritability, concentration difficulty, 
insomnia) and represents the tripartite model spectrum of negative affect that characterizes 
all emotional disorders. The General Distress: Anxious Symptoms scale assesses anxious 
mood and other symptoms that empirically do not differentiate among various anxiety 
disorders. Analogously, the General Distress: Depressive Symptoms scale includes items 
assessing depressed mood and other nonspecific symptoms of mood disorder. The General 
Distress: Mixed Symptoms (hereafter Mixed Symptoms) scale was preferred to the other 
two because it captures symptoms of emotional distress that are identified in modern 
nosologies as being symptoms of both anxiety and depressive disorders (Watson et al., 
1995).
Two scales contain items selected to index specific symptom dimensions of either anxiety or 
depression. Anxious Arousal features 17 items related to somatic tension and hyperarousal 
(e.g., dizziness, shortness of breath, shaking hands) that reflect the anxious arousal 
dimension of the tripartite model. In contrast, the 22-item Anhedonic Depression scale 
assesses the anhedonia tripartite domain with items related to loss of interest and positive 
affective states (e.g., enjoyment, happiness). On all scales, respondents indicated on a five-
point scale to what extent they had experienced each symptom (1 = not at all, 5 = extremely) 
“during the past week, including today.”
Prior research on the latent architecture of the MASQ Anhedonic Depression scale in this 
and other samples (Kendall et al., 2016; Keogh & Reidy, 2000; Watson, Clark, Weber, & 
Assenheimer, 1995) indicates that it is multidimensional. That is, during MASQ 
development, some items (i.e., those tapping the low end of positive affect such as “Felt 
really bored,” “Felt withdrawn from other people,” “Felt unattractive”) cohered with MASQ 
items intended to assess negative affect (Watson et al., 1995). A recent investigation into the 
latent structure of the MASQ Anhedonic Depression scale using bifactor analysis found 
support for an overarching general factor uniting all 22 items, but also for separate group 
factors for the 8 items tapping low positive affect (and likely contaminated with negative 
affect variance) and the remaining 14 tapping the high end of positive affect (Kendall et al., 
2016). Kendall et al. recommended separating these item sets in future research. Thus, to 
achieve maximum discrimination between anhedonia and the other two tripartite 
dimensions, we omit the 8 items thought to be saturated with negative affect and include in 
our Anhedonic Depression scale only those 14 items assessing high positive affect (e.g., 
“Felt really cheerful,” “Looked forward to things with enjoyment,” “Felt really good about 
myself”). Following MASQ scoring conventions, these 14 items were reverse-scored such 
that higher values represent greater anhedonia.
The MASQ has demonstrated excellent psychometric properties in cross-sectional research. 
Scale reliability values are consistently .80 and above across student, community, and patient 
samples (Watson et al., 1995). The pattern of scale correlations is in line with tripartite 
model predictions, such that the three General Distress dimensions are highly 
intercorrelated, the General Distress dimensions are moderately correlated with Anxious 
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Arousal and Anhedonic Depression, and Anxious Arousal and Anhedonic Depression are 
weakly correlated (Watson et al., 1995). Also supporting the discriminant validity of the 
specific dimensions, Anxious Arousal is far more related than Anhedonic Depression to 
conventional measures of anxiety, whereas Anhedonic Depression is more closely connected 
than Anxious Arousal to measures of depression. In the present study, scale reliability 
estimates at baseline were all above .88 (range: .88 to .93).
Structured Clinical Interview for DSM-IV, Non-Patient Edition (SCID-I/NP)—The 
SCID-I/NP (First et al., 2002) assesses DSM-IV (American Psychiatric Association, 1994) 
diagnoses. The SCID-I/NP was administered at baseline to assess lifetime history of 
emotional disorders (i.e., current and past diagnoses) up to and including Time 1. Diagnoses 
occurring after Time 1 were not examined in this study to preserve the temporal precedence 
of diagnostic history relative to symptom trajectories. Each completed SCID-I/NP was 
presented at a consensus meeting led by doctoral-level supervisors. To qualify for a 
diagnosis, participants had to meet DSM-IV criteria and be assigned a clinical severity rating 
(CSR; Di Nardo & Barlow, 1988) of four or greater for that diagnosis. CSRs are used to 
quantify symptom severity and the amount of impairment and distress present, and they are 
rated on a scale of 0–8, with a 0 indicating no notable symptoms, distress, or interference, 1–
3 indicating subclinical severity, and ratings of four and higher indicating clinical 
significance. Inter-rater reliability for both CSRs (Pearson rs > .70) and DSM-IV diagnoses 
(kappas > .65) were in the acceptable to good range (see Zinbarg et al., 2010, for more 
detail). The diagnostic frequencies (and percentages) at baseline were 112 (18%) major 
depressive disorder, 7 (1%) dysthymia, 6 (1%) panic disorder, 53 (9%) social phobia, 13 
(2%) obsessive-compulsive disorder, 4 (1%) posttraumatic stress disorder, 13 (2%) 
generalized anxiety disorder, and 33 (5%) specific phobia. There were 48 comorbid cases 
(8% of sample) at baseline with a history of both an anxiety and depressive disorder.
Procedures
Participants were recontacted 10 months after baseline, and each subsequent wave, to 
complete the study assessment battery. Each successive assessment was administered 
between 10 and 18 months after the prior assessment, and the mean interval between follow 
ups was 0.94 year (SD = 0.12). If a participant was not reachable or available to complete a 
given assessment (time t) in the 18 months following the previous wave (time t-1), he or she 
was still contacted to participate in the following wave (time t+1). The available sample 
sizes for the MASQ at baseline and the four follow up points were 604, 443, 326, 340, and 
360. We compared 69 baseline respondents who did not participate at any subsequent wave 
with those who did, and we found that attritors did not differ from other participants on any 
baseline demographic or psychopathology index, that they reported higher levels of baseline 
Anxious Arousal, t(601) = 2.00, p < .05. In addition, baseline variables generally were not 
related to missingness at any single wave. The exceptions were that elevated Anxious 
Arousal predicted missingness at Time 4, t(601) = 2.54, p < .05, and Time 5, t(601) = 2.93, p 
< .05, and elevated Mixed Symptoms predicted missingness at Time 5, t(601) = 2.93, p < .
05.
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The MASQ was completed through a secure website at each assessment wave, and 
participants were mailed a check upon completion. The Institutional Review Boards at 
Northwestern University and UCLA approved all study procedures.
Statistical Analysis
We specified latent curve models (LCMs) to understand how each symptom domain changed 
over time and the extent to which they changed in concert. LCM is well suited for those 
research objectives because it assumes, unlike other statistical frameworks for studying 
multivariate change (e.g., autoregressive cross-lagged models), an underlying growth 
process that shapes the trajectory of observed repeated measures (Bollen & Curran, 2006; 
Duncan & Duncan, 2004). Figure 1 presents a path diagram of a bivariate LCM that assumes 
linear change in both constructs—here we use Mixed Symptoms and Anxious Arousal as 
examples—over time. However, the multivariate LCM can easily be extended to include 
additional constructs and alternate functional forms of change (e.g., polynomial models); our 
example focuses on the linear bivariate case for simplicity. In the diagram, the LCM slope 
factor means are represented by the regression of each factor on a constant value of unity 
(shown in the triangle). The weights of these regressions (labeled α2 and α4) reflect the 
direction (i.e., sign of the coefficient) and rate (i.e., magnitude of the coefficient) of 
symptom change. Meanwhile, the random portion of each factor is represented by a separate 
latent variable influencing the growth factors. Thus, the slope factor variances (ψ22 and ψ44) 
reflect the degree of between-person variability in symptom trajectories, whereas the slope 
factor covariance (ψ42) indexes the extent to which the two symptom trajectories are 
correlated over time.
The first step in our analysis was to find the optimal functional form of change over time for 
each symptom domain independently. In univariate models, we evaluated a linear growth 
model in which slope factor loadings were specified as 0 (Time 1 [T1]), 1 (T2), 2 (T3), 3 
(T4), and 4 (T5), and all intercept loadings were fixed at 1. We compared that linear model, 
which assumes a constant rate of symptom change over follow up, with a quadratic model 
that allows for a nonlinear trajectory (i.e., acceleration or deceleration in growth). In 
quadratic models, we reparamaterized the factor loadings such that time was centered on T3 
(i.e., linear trend factor loadings: −2, 1, 0, 1, 2) to avoid estimation problems related to linear 
dependence among the linear and quadratic factors (Stoolmiller, 1995). A likelihood ratio 
test (LRT) of nested models was used to judge whether the addition of quadratic effects 
significantly improved model fit.
After we characterized the form of symptom growth in univariate analyses, we examined 
correlations among symptom trajectories. In a trivariate LCM, we examined the cross-
construct covariances between the intercepts and rates of change for each pair of symptom 
dimensions. In this trivariate model, cross-construct within-time error covariances (e.g., the 
covariance between the Time 3 Mixed Symptoms error term and Time 3 Anxious Arousal 
error term) were freely estimated. A LRT indicated that allowing these error covariances 
significantly improved fit relative to a model in which they were fixed to zero, χ2Δ(3) = 
389.46, p < .001. Further, these error covariances were constrained to equality over time for 
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model parsimony; another LRT showed that these constraints did not significantly degrade 
model fit for any of the three pairs of symptom dimensions, χ2Δ(4) < 7.50, ps > .10.
After determining the best fitting trivariate LCM, we compared it to the latent curve model 
with structured residuals (LCM-SR; Curran, Howard, Bainter, Lane, & McGinley, 2014), an 
alternate—and closely related—model of multivariate change. The LCM-SR is a hybrid of 
LCM and autoregressive cross-lagged models that specifies autoregressive and cross-lagged 
paths among adjacent residuals of the manifest variables, as opposed to the manifest 
variables themselves. Thus, the LCM-SR is an extension of the LCM that includes includes 
autoregressive and cross-lagged regressions of residual terms of repeated measures at time t 
on residual terms of repeated measures at time t-1 (regressions onto more distal repeated 
measure residuals [e.g., t-2] are possible but not tested here). These additional parameters 
represent the degree to which departures from one’s expected trajectory at time t in one 
construct predict deflections from one’s expected trajectory at time t+1 in the other 
construct.
After empirically comparing the LCM and LCM-SR (and retaining the LCM), we examined 
individual differences in symptom change as a function of gender and comorbidity. This 
testing was performed in a multiple-groups structural equation modeling context, which 
allows model parameters to vary across population subgroups. We chose the multiple-group 
approach instead of specifying the covariates as exogenous predictors of growth factors 
because the latter procedure only permits an examination of covariate effects on factor 
means (see Bollen & Curran, 2006), whereas our primary interest was in how gender and 
comorbidity influenced growth factor covariances (i.e., correlation of growth trajectories 
across symptom dimensions). Testing followed a two-step process. First, in univariate 
LCMs, we compared models in which factor means were constrained to equality across the 
subgroups or varied freely. The LRT of the fit of these nested models indicated whether the 
shape of change in each symptom dimension was constant across subgroups. Second, in a 
series of bivariate LCMs, we compared models in which the factor variances and 
covariances were equated versus freely estimated across subgroups. A significant LRT in 
this step would indicate that the sample variance in the rate of change or the correlation in 
change across symptom domains differed across subgroups. If an LRT was significant in 
either step, we inspected the model modification indices (MIs) to determine which, if any, of 
the model constraints led to poor fit. It should be noted that such post hoc inspection of MIs 
can lead to model overfitting, or picking up on chance variation in a given sample, and we 
therefore proceed with caution when interpreting MIs (e.g., MacCallum, 2001). Due to the 
increasing number of significance tests, we followed an analog of the protected t-test 
procedure whereby we only proceeded to examine the MIs for means and (co)variances if 
the omnibus LRT was significant (Cohen, Cohen, West, & Aiken, 2003).
We assessed model fit with the comparative fit index (CFI), Tucker-Lewis index (TLI), root 
mean square error of approximation (RMSEA), and standardized root mean square residual 
(SRMR). We compared sample estimates of these criteria to guidelines for acceptable fit 
offered by Hu and Bentler (1999). We also judged model fit on the basis of localized areas of 
strain and the size and interpretability of parameter estimates. We used the robust maximum 
likelihood estimator in Mplus (version 7.3, Muthén & Muthén, 1998–2014) for all analyses 
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to account for non-normality in MASQ scale distributions, and missing data due to attrition 
were accommodated using full information maximum likelihood estimation procedures (see 
Allison, 2003).
Results
Descriptive Statistics
Table 1 presents the means and standard deviations of each symptom domain across time. 
Average symptom levels were comparable to undergraduate norms reported in studies of 
MASQ psychometrics (Watson et al., 1995). Also, Mixed Symptoms and Anxious Arousal 
appeared to decline over time, whereas there was a small overall increase in Anhedonic 
Depression. The corresponding effect sizes representing change between the symptom mean 
at T1 to the symptom mean at T5, expressed in Cohen’s d (using standard deviations at T1), 
were −0.47, −0.41, and 0.06 for Mixed Symptoms, Anxious Arousal, and Anhedonic 
Depression, respectively.
Measurement Invariance
Measurement invariance was examined prior to fitting LCMs to verify that any observed 
symptom change over time was true change in the underlying construct rather than 
variability across time in the measurement properties of MASQ items (see Horn & McArdle, 
1992). To evaluate measurement invariance, we estimated a series of confirmatory factor 
analyses (CFAs) for each symptom dimension involving the two most distant waves (i.e., T1 
and T5). That is, we compared CFAs with cross-time equality constraints on factor loadings 
and indicator intercepts with models in which those parameters were allowed to vary freely. 
In this analysis, each scale item was treated as a separate indicator of a latent variable 
representing the relevant symptom dimension (e.g., each of the 17 Anxious Arousal items 
was treated as an indicator of an Anxious Arousal factor). For each scale we tested for weak 
(i.e., loadings but not intercepts) and strong (i.e., loadings and intercepts) measurement 
invariance.
The results supported partial invariance for all three scales. According to LRTs and 
comparison of other model fit indices (e.g., CFI, RMSEA), 1 factor loading was allowed to 
vary across time for Anhedonic Depression, whereas all factor loadings were time-invariant 
for Mixed Symptoms and Anxious Arousal. Regarding the intercepts, 4 (out of 15) on the 
Mixed Symptoms scale, 6 (out of 14) on the Anhedonic Depression scale, and 2 (out of 17) 
on the Anxious Arousal scale were non-invariant over time. Thus, we concluded that partial 
invariance obtained and we could proceed with the LCM. (Full results are available upon 
request from the first author.)
Unconditional Univariate Latent Curve Models
This series of LCMs aimed to quantify the rate and variability of symptom growth over time. 
The observed patterns of change are depicted in Figure 2. We first compared linear and 
quadratic models to evaluate the constancy of change in each symptom domain. Linear 
models provided adequate fit for Mixed Symptoms, χ2(14) = 25.52, p < .05; CFI = .97; TLI 
= 0.98; RMSEA = 0.04; SRMR = .06; Anxious Arousal, χ2(14) = 40.40, p < .001; CFI = .
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89; TLI = 0.92; RMSEA = 0.08; SRMR = .13; and Anhedonic Depression, χ2(14) = 29.44, 
p < .01; CFI = .96; TLI = 0.97; RMSEA = 0.04; SRMR = .06. However, chi-square 
difference tests indicated that the addition of a quadratic factor—including the factor mean, 
variance, and covariances among the intercept and linear trend factors—significantly 
improved model fit for each dimension: Mixed Symptoms, χ2Δ(4) = 56.11, p < .001; 
Anxious Arousal, χ2Δ(4) = 64.72, p < .001; Anhedonia, χ2Δ(4) = 47.72, p < .001 (see Table 
2 for quadratic model fit statistics).
Table 2 shows the parameter estimates—including factor means, variances, and correlations
—from the quadratic LCMs. As expected, the means of all intercept factors differed from 
zero. More significantly, the large intercept variance estimates indicated wide cross-sectional 
variation on each symptom dimension. The linear trend estimates1 for Mixed Symptoms and 
Anxious Arousal were negative—indicative of a downward trajectory—and statistically 
significant. There was also significant variability around the linear trend estimates, 
suggesting that not all participants exhibited an equally precipitous drop in symptoms over 
follow up.
Moreover, a statistically significant quadratic factor mean was observed for Mixed 
Symptoms. The positive sign of the coefficient indicated that the decline in Mixed 
Symptoms decelerated over the course of follow up, such that, on average, the linear trend 
became approximately 0.56 units2 more positive at successive intervals. The quadratic trend 
for Anxious Arousal was positive but not statistically significant. However, there was 
significant variability around that estimate, indicating a wide degree of variation in the 
expected curvature in Anxious Arousal symptom change over time.
The Anhedonic Depression trajectory diverged from that of Mixed Symptoms and Anxious 
Arousal. The average linear trend over follow up was positive, although it only approached 
conventional levels of statistical significance. The mean quadratic trend was positive but not 
statistically significant. Further, significant variability in the quadratic factor revealed that 
the amount of change in change over time varied across participants.
Unconditional Trivariate Latent Curve Model
The next analysis allowed us to examine covariances in properties of symptom change. The 
correlations among intercept factors—representing symptom levels at Time 3, since time 
was centered at the middle assessment wave—provided insight into cross-sectional 
associations between symptom domains. Mixed Symptoms had a strong association with 
Anxious Arousal (r = .73). In contrast, the intercept correlations of Anhedonic Depression 
with Mixed Symptoms (r = .36) and Anxious Arousal (r = .20) were small-to-moderate.3
1In the quadratic model, the (simple) linear trend estimates are interpreted as the slope of the tangent to the curve at the model 
intercept (i.e., Time 3). The linear trend estimates from the quadratic LCMs were virtually identical to the slope factor mean estimates 
from linear LCMs (results available upon request).
2The rate of change in the linear trend per unit time is double the quadratic factor mean (e.g., for Mixed Symptoms: 2 × 0.28).
3In an exploratory analysis, we respecified the intercept location at the other assessment waves to figure out whether cross-sectional 
associations between the symptom domains changed over the course of the study. We did not detect any systematic trends in the size 
or pattern of intercept intercorrelations across waves. The range of intercept correlations for Mixed Symptoms and Anxious Arousal 
was .71-.78; that of Mixed Symptoms and Anhedonic Depression was .24-.36; and that of Anxious Arousal and Anhedonic 
Depression was .09-.20.
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Table 3 presents zero-order correlations between growth factors. We focus on the cross-
construct correlations between linear and quadratic factors to understand the degree of 
correspondence in change over time among tripartite model dimensions. The linear change 
in Mixed Symptoms was significantly and positively related to that in Anxious Arousal (r = .
59). In contrast, the correlation in linear change between Mixed Symptoms and Anhedonic 
Depression (r = .27) did not reach statistical significance, and that between Anhedonic 
Depression and Anxious Arousal (r = -.02) was non-significant and almost nil. Constraining 
the covariances among linear factors to equality produced a significant decrement in model 
fit, χ2Δ(2) > 11.30, p < .01, indicating that these correlations differ significantly in 
magnitude. An analogous pattern of correlations emerged for the quadratic factors. The 
Mixed Symptoms quadratic trend (i.e., the upward bend in trajectory over follow up) was 
strongly related to that of Anxious Arousal (r = .75) but not Anhedonic Depression (r = .35). 
There was a small association between quadratic trends in Anhedonic Depression and 
Anxious Arousal (r = .15).4 As with the linear factors, fixing all three quadratic factor 
covariances to equality significantly worsened model fit, χ2Δ(2) > 6.47, p < .05, again 
suggesting that tripartite quadratic trajectories are not all related equally.
Alternate Model for Multivariate Change
As described above, we aimed to compare the fit of the LCM to the LCM-SR to determine 
whether any prospective relations among the symptom constructs were evident after 
accounting for the latent growth processes thought to shape tripartite symptom trajectories. 
We began by specifying a trivariate LCM-SR to correspond to our final trivariate LCM. As 
in the LCM, we specified a quadratic functional form for all three constructs. The trivariate 
LCM-SR produced an improper solution; the estimates for the variances of the linear and 
quadratic trends for all symptom constructs were negative. (We also observed a negative 
variance estimate for the linear trend in sensitivity analyses that omitted the quadratic 
factor.) In ad hoc analyses we constrained the variances of the linear and quadratic factors to 
zero. These constraints led to a reasonable model fit, χ2(93) = 81.95, p = .80; CFI = 1.00; 
TLI = 1.00; RMSEA = 0.00; SRMR = .05; however, none of the cross-lagged paths were 
significantly different from zero (all standardized cross-lags were smaller than |.04|). In other 
words, they did not explain the longitudinal correlation among symptom domains above and 
beyond the latent growth trajectories. We interpreted this set of results as indicating that 
cross-lagged paths across symptom constructs do not add meaningfully to our understanding 
of the nature of symptom co-development in this sample. Thus, we rely on the multivariate 
LCM for interpretations of the direction, size, and covariance of symptom trajectories, and 
we carry it forward to examine predictors of individual differences in those trajectories.
4We mentioned above that our main analyses omitted the 8 Anhedonic Depression items previously found to be saturated with 
negative affect variance and meaningfully distinguished in bifactor analyses from the 14 Anhedonic Depression items tapping the high 
end of positive affect (Kendall et al., 2015; Watson et al., 1995). Here we present the pattern of growth for a dimension comprised of 
those 8 Anhedonic Depression items that appear to assess the low end of positive affect. Linear growth for this dimension was negative 
(b = −0.82, p < .001) with significant interindividual variability around that estimate. The quadratic factor mean was not significantly 
different from zero. In parallel process growth models, the Anhedonic Depression intercept was very closely related to the intercepts 
for Mixed Symptoms (r = .93) and Anxious Arousal (r = .70). Moreover, the correlation in Anhedonic Depression’s linear trend with 
Mixed Symptoms (r = .77) was remarkably high; it had a more moderate longitudinal association with Anxious Arousal (r = .33). 
Paralleling the pattern of linear trend associations, the correlations among quadratic factors were .90 for Mixed Symptoms and .64 for 
Anxious Arousal. Overall, these results supported the notion that a subset of MASQ Anhedonic Depression items may reflect negative 
affect and therefore might not be optimal indicators of the anhedonia dimension (for details, see Kendall et al., 2015).
Conway et al. Page 12
J Abnorm Psychol. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Multiple-Group Multivariate Growth Models
When growth factor means were constrained to equality across gender, model fit worsened 
only in the Anhedonic Depression model, χ2Δ(2) = 10.79, p < .01. Inspection of the MIs 
revealed that only the model intercept differed across gender, χ2(1) = 8.17, p < .01. 
Specifically, men (M = 44.66) had higher Anhedonic Depression levels at the study mid-
point than women (M = 41.80). No factor variances or cross-construct covariances varied as 
a function of gender.
Factor means were found to differ across comorbidity status for all three symptom 
constructs, χ2Δ(3) > 10.30, ps < .01. For Mixed Symptoms, MIs indicated that the intercept 
factor mean was higher for comorbid cases (comorbid group: M = 33.16; non-comorbid 
group: M = 28.44), χ2(1) = 18.80, p < .001. Further, the quadratic factor mean was larger for 
comorbid cases (comorbid group: M = 1.15, SE = 0.45, p < .05; non-comorbid group: M = 
0.20, SE = 0.11, p = .06), χ2(1) = 15.49, p < .001. For Anhedonic Depression, the intercept 
factor mean was also higher for comorbid cases (comorbid group: M = 46.56, SE = 1.53, p 
< .001; non-comorbid group: M = 42.34, SE = 0.50, p < .001), χ2(1) = 9.31, p < .01. For 
Anxious Arousal, only the quadratic factor mean differed across groups (comorbid group: M 
= 0.86, SE = 0.25, p < .001; non-comorbid group: M = 0.06, SE = 0.10, p = .56), χ2(1) = 
15.73, p < .001.5 Factor variances and cross-construct covariances did not vary significantly 
by comorbidity status.
Discussion
We mapped the trajectory of core dimensions of emotional disorders across five annual 
assessment waves beginning in adolescence. We observed reductions over follow up in 
negative affect and anxious arousal symptom levels, but no significant change in anhedonia. 
We also found that the rate of change in these symptoms appeared to change over time; that 
is, emotional disorder development during this period was not entirely linear. Just as 
important, we demonstrated that the rate of symptom change—and changes in the rate of 
change—are not necessarily correlated across tripartite domains. Specifically, anhedonia 
progressed fairly independently from negative affect and anxious arousal.
The patterns of change in tripartite domains suggest that emotional disorder symptoms do 
not uniformly rise or fall during emerging adulthood. Consistent with the maturity principle 
(Caspi et al., 2005), which posits that accomplishment of normative life tasks (e.g., choosing 
a career, beginning serious romantic relationships) at the transition to adulthood should be 
accompanied by reductions in trait negative affectivity, we found declining trajectories for 
negative affect and anxious arousal (cf. Robins et al., 2001). In contrast, adolescents did not 
“mature out” of anhedonic symptoms at the transition to adulthood. If anything, these 
symptoms appeared to worsen somewhat over this period. This observation accords with 
findings from community studies that document substantial continuity of depressive 
5Supplementing our analyses of comorbidity effects on growth factor means, we regressed these factor means on a trichotomous 
independent variable reflecting EPQ-R Neuroticism tertiles (see Methods), a proxy for baseline emotional disorder risk (similar to a 
history of diagnostic comorbidity). In line with previous studies in community and patient samples (e.g., Brown & Rosellini, 2011; 
Galambos et al., 2006), we found that higher Neuroticism levels were associated with significantly greater baseline levels and steeper 
linear declines across all three symptom dimensions, consistent with regression to the mean (full results available upon request).
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symptoms and disorders from adolescence to emerging adulthood, including peak rates of 
depressive disorder recurrence (e.g., Rohde et al., 2013). Moreover, the persistence of 
anhedonia is in line with the theory that the “demographically dense” transition to adulthood
—featuring novel social challenges such as leaving home and navigating long-term romantic 
relationships—set the stage for depression among vulnerable people (see Arnett, 2000). 
However, such changes in anhedonia might also be consistent with a wide range of other 
developmental processes (e.g., normative development of reward processing systems, less 
time for engagement in pleasurable activities). Additional research is needed to determine to 
what extent developmental challenges at the transition to adulthood shape the naturalistic 
course of emotional disorder features.
Our findings extend prior developmental studies by distinguishing between general and 
differentiating features of emotional disorders. That is, previous work typically has involved 
assessments that conflate the core dimensions of anxiety and depression (cf. Clark & 
Watson, 1991). Therefore, the naturalistic course of the specific and distinctive variance in 
observed scores on depressive symptom measures have been associated with fluctuations in 
anxiety to an unknown extent (and vice versa). By modeling the tripartite dimensions over 
time, we charted separate courses for negative affect, which characterizes all emotional 
disorders, and more specific components of anxiety and depression. This distinction proved 
revealing, as negative affect declined monotonically over late adolescence, whereas 
anhedonia—a specific dimension to unipolar depression and social phobia—exhibited 
comparatively little growth (in the opposite direction). This result aligns with previous 
treatment research that shows anhedonia is the emotional disorder dimension least likely to 
change with intervention (Craske et al., in press).
Just as important as the symptom trajectories were the correlations among those trajectories. 
We showed, for the first time, that negative affect, anhedonia, and anxious arousal symptoms 
do not travel together as a “lump” across development. The correspondence between linear 
change in anhedonia and negative affect was nearly half (standardized coefficient ~= .30) 
that of anxious arousal and positive affect (~ .60). The standardized relation between 
anhedonia and anxious arousal linear factors was virtually nil. Although this pattern of 
correlations does not rule out meaningful associations between aspects of change in 
anhedonia with other tripartite dimensions, it did appear that anhedonia development was 
more weakly related to negative affect and anxious arousal than those two constructs were 
with one another. This finding is consistent with our knowledge of the cross-sectional 
architecture of emotional disorders (e.g., Mineka et al., 1998), and they support the notion 
that anxious arousal and anhedonia represent independent pathways to emotional disorders.
The nature of symptom growth—including relations among symptom trajectories—did not 
differ significantly for men and women. This result might be attributable to our sampling 
procedure, which overselected men at risk for emotional disorders. In other words, our data 
suggest that, if risk status is held constant, gender differences in the time course of symptom 
development in late adolescence are small. Alternatively, this pattern may be specific to the 
developmental stage under study (i.e., the transition from adolescence to adulthood). In early 
adolescence, gender differences in the rate of depression change, and perhaps the correlation 
between the rate of depression and anxiety symptom change, should be more apparent 
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according to established theory and longitudinal data (e.g., Ge et al., 1994; Lubke et al., 
2015). More generally, we might expect symptom trajectories to respond to emotion-relevant 
biological (e.g., hormonal) and social (e.g., peer relations) processes as they come online, 
which can occur at different ages, and in qualitatively different fashion, for men and women 
(see, e.g., Hankin & Abramson, 2001).
Unlike gender, comorbidity appeared to have a systematic influence on the developmental 
map of tripartite symptoms. We found a pattern of elevated intercept levels among comorbid 
cases, as might be expected given the positive association between comorbidity and overall 
severity of emotional disorders (e.g., Brown, Campbell, Lehman, Grisham, & Mancill, 
2001). We also found that when symptoms tended to decline over follow up—as was the 
case for negative affect and anxious arousal—the typical path of improvement was slowed 
over time in the comorbid group. That is, the normative trajectory of symptom reductions 
was not as steep—as reflected in larger quadratic factor means—among comorbid cases. 
However, counter to predictions, there was no evidence of differences in cross-construct 
covariances of symptom trajectories by comorbidity status. This result implies that the 
developmental trajectories of anxiety- and depression-specific symptoms are no more 
closely correlated for comorbid cases than for others. Stated differently, the unique 
components of anxiety and depression grow independently over time even among those who 
possess vulnerabilities for both anxiety and depression.
Several study limitations point to directions for future research. First, as observed earlier, the 
present sample was overselected for elevated trait negative affectivity, and results may not be 
characteristic of the general adolescent population. Although the average symptom levels in 
our sample were no higher than those reported in normative undergraduate samples (Watson 
et al., 1995), it is possible that regression to the mean may have biased our trajectory 
estimates, at least for high risk subgroups. We note, however, that a recent simulation study 
suggests that this type of oversampling does not seem to bias appreciably effect size 
estimates in behavioral research (Hauner, Zinbarg, & Revelle, 2014). Second, our analysis 
spans a critical period of emotional disorder development, but our results cannot be assumed 
to apply to other developmental epochs. Theory suggests that trait negative affectivity should 
continue to decline as young adults age (e.g., Caspi et al., 2005), but very few longitudinal 
data on the progression of relevant emotional disorder symptoms are available. Analogously, 
fluctuations in anhedonia may be most pronounced in early adolescence, when the incidence 
of depressive disorders climbs markedly. In fact, disrupted reward processing is evident even 
in disorder-free children who are at risk for depression (Gotlib et al., 2010). Thus, future 
research is needed to discover the time course of anhedonic (and other) symptoms in early 
developmental epochs. Third, the MASQ has undergone psychometric development since 
the start of the Youth Emotion Project. Its successor, the Inventory of Depression and 
Anxiety Symptoms (IDAS; Watson et al., 2007), includes symptom dimensions that provide 
coverage of additional specific features thought to differentiate anxiety and depression (e.g., 
lassitude, traumatic intrusions). Future empirical work with the IDAS and other multifaceted 
transdiagnostic models such as the trilevel model (e.g., Naragon-Gainey, Prenoveau, Brown 
& Zinbarg, in press; Prenoveau et al., 2010) will shed more light on change in emotional 
disorder risk across development. Fourth, in some research contexts it can be theoretically 
and empirically challenging to differentiate symptom dimensions from related temperament 
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and personality processes (e.g., Krueger & Tackett, 2003). Our focus here was on change in 
emotional disorder symptoms, but it remains unclear to what extent the personality 
dimensions underlying anxiety and depression follow the same pattern of development. 
Future work is needed to directly compare, and examine causal influences between, 
symptom versus personality development over time (e.g., Clark, 2005; Morey & Hopwood, 
2013). Fifth, 11% of the baseline sample did not participate in any follow up wave, and 
attritors endorsed higher levels of baseline anxious arousal symptoms. Although we used 
full information maximum likelihood, which is preferred to other methods for handling 
missing data (e.g., listwise deletion), differential attrition may still limit to some extent the 
generalizability of the results. Finally, (multiple-indicator) latent variable repeated measures 
can be incorporated into LCM to remove measurement error from growth factor indicators 
(e.g., Preacher, Wichman, MacCallum, & Briggs, 2008). Here we used single indicator 
repeated measures (i.e., MASQ scale means) to limit model complexity; however, it must be 
acknowledged that the factor indicator variance included measurement error.
In sum, we charted the trajectories of core dimensions of emotional disorders from 
adolescence into emerging adulthood. We found that the developmental trends for negative 
affect, anhedonia, and anxious arousal can look very different—and occasionally proceed in 
opposite directions—during this period. We also discovered that the rates of change in these 
symptom domains are not always strongly (or even minimally) correlated. Together, these 
results suggest that divergent pathways to emotional disorders are possible during this key 
developmental stage.
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Figure 1. 
Path diagram for the bivariate linear latent curve model for Mood and Anxiety Symptom 
Questionnaire Mixed Symptoms and Anxious Arousal measured at five occasions. η1 and η3 
represent intercept factors, whereas η2 and η4 represent linear trend factors. The ψs 
represent factor variances and covariances, and the αs denote factor means. Following path 
diagram conventions, rectangles represent observed variables and circles represent latent 
variables. Growth factor means are represented by regressing the factors onto a constant 
(unity). Within-time residual covariances are omitted for clarity of presentation.
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Figure 2. 
Repeated measures of Mood and Anxiety Symptom Questionnaire scales. (A) General 
Distress: Mixed Symptoms; (B) Anhedonic Depression; (C) Anxious Arousal.
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Table 2
Unstandardized Parameter Estimates from Unconditional Univariate Latent Growth Models for Mixed 
Symptoms, Anxious Arousal, and Anhedonic Depression
Parameter Mixed
Symptomsa
Anxious
Arousalb
Anhedonic
Depressionc
Intercept variance 62.76 (7.54)*** 47.09 (7.32)*** 73.62 (7.65)***
Linear trend mean
−1.13 (0.13)*** −0.82 (0.10)*** 0.28 (0.16)†
Linear trend variance 2.45 (0.64)*** 2.05 (0.61)*** 5.27 (0.93)***
Linear trend-intercept r −.15 (.12) −.09 (.12) .01 (.10)
Quadratic trend mean 0.28 (0.11)** 0.13 (0.10) 0.13 (0.12)
Quadratic trend variance 1.30 (0.46)** 1.66 (0.41)*** 1.73 (0.57)**
Quadratic trend-intercept r
−.44 (.10)*** −.52 (.10)*** −.45 (.08)***
Quadratic trend-linear trend r −.20 (.20)
−.50 (.20)* .13 (.17)
Note. N = 606. Standard errors appear in parentheses.
†p < .10,
*p < .05,
**p < .01,
***p < .001.
a
Model fit: χ2(10) = 9.04, p = .53; CFI = 1.00; TLI = 1.00; RMSEA = 0.00; SRMR = .03.
b
Model fit: χ2(10) = 9.77, p = .46; CFI = 1.00; TLI = 1.00; RMSEA = 0.00; SRMR = .05.
c
Model fit: χ2(10) = 16.05, p = .10; CFI = .98; TLI = 0.98; RMSEA = 0.03; SRMR = .06.
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